Short Interest in Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) Grows By 253.7%

Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) was the target of a large growth in short interest in August. As of August 31st, there was short interest totaling 391,908 shares, a growth of 253.7% from the August 15th total of 110,804 shares. Currently, 20.1% of the shares of the stock are short sold. Based on an average daily volume of 350,017 shares, the days-to-cover ratio is presently 1.1 days.

Institutional Investors Weigh In On Defiance Daily Target 2X Long LLY ETF

A hedge fund recently bought a new stake in Defiance Daily Target 2X Long LLY ETF stock. Jump Financial LLC acquired a new stake in Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 9,186 shares of the company’s stock, valued at approximately $234,000. Jump Financial LLC owned approximately 0.54% of Defiance Daily Target 2X Long LLY ETF at the end of the most recent reporting period.

Defiance Daily Target 2X Long LLY ETF Stock Down 1.7%

Shares of NYSEARCA LLYX traded down $0.40 during midday trading on Friday, hitting $22.91. The company had a trading volume of 241,569 shares, compared to its average volume of 441,018. Defiance Daily Target 2X Long LLY ETF has a twelve month low of $12.18 and a twelve month high of $31.19. The business has a 50-day simple moving average of $26.37 and a two-hundred day simple moving average of $22.72.

About Defiance Daily Target 2X Long LLY ETF

The Defiance Daily Target 2X Long LLY ETF (LLYX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses. LLYX was launched on Aug 7, 2024 and is issued by Defiance.